As China benefits from being “first in and first out” of the COVID-19 pandemic, it has become increasingly attractive to investors both locally and from around the globe. This report reveals investor intentions in Mainland China by market and by sector, and their cap rate expectations.
2021 Mainland China Investor Intentions and Cap Rate Survey
23/04/2021
Related Insights
Insights
Japan's Pharmaceutical Cold Chain is Facilitating the Supply of New Drugs and Vaccines
The pharmaceutical cold chain has experienced increasing demand in recent years due to rapid developments in biopharmaceuticals and regenerative medicine, a trend that looks set to grow with the rollout of vaccines and other treatments for COVID-19.